Bortezomib attenuates HIF-1- but not HIF-2-mediated transcriptional activation

Bortezomib is the first proteasomal inhibitor (PI) to be used therapeutically for treating relapse cases of multiple myeloma and mantle cell lymphoma. A proposed mechanism for its action is that it prevents the proteasomal degradation of proapoptotic proteins, leading to enhanced apoptosis. Although...

Full description

Saved in:
Bibliographic Details
Main Authors: Abd Aziz, Noraini, Stanbridge, Eric J., Shafee, Norazizah
Format: Article
Language:English
Published: Spandidos Publications 2015
Online Access:http://psasir.upm.edu.my/id/eprint/36675/1/Bortezomib%20attenuates%20HIF-1-%20but%20not%20HIF-2-mediated%20transcriptional%20activation.pdf
http://psasir.upm.edu.my/id/eprint/36675/
https://www.spandidos-publications.com/10.3892/ol.2015.3545/abstract
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first